Clinical Guidelines on the Management of Hepatitis C


Hepatitis C virus (HCV) is a major health care concern in the UK affecting some 200 000 to 400 000 individuals. The majority of these patients will have chronic HCV infection and many will develop chronic liver disease with the risk of developing cirrhosis and hepatocellular carcinoma (HCC). Successful treatment will arrest the progression of liver disease and so prevent the serious complications of chronic HCV infection. In addition, treatment willreduce the numbers of HCV infected individuals.